Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293

Current state of the art in peptide-based gene delivery

(2022) Roja Hadianamrei et al.   JOURNAL OF CONTROLLED RELEASE

Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes

(2021) Laura Abaandou et al.   Cells

Top product forecasts for 2022

(2021) Lisa Urquhart   NATURE REVIEWS DRUG DISCOVERY

Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!

(2020) Nina Bono et al.   Pharmaceutics

Developing therapeutic monoclonal antibodies at pandemic pace

(2020) Brian Kelley   NATURE BIOTECHNOLOGY

A decade of immune-checkpoint inhibitors in cancer therapy

(2020) Caroline Robert   Nature Communications

NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation

(2020) Gemma Carreras-Badosa et al.   BIOMATERIALS

Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics

(2018) Sonia Gutiérrez-Granados et al.   CRITICAL REVIEWS IN BIOTECHNOLOGY

Recombinant Antibody Production in CHO and NS0 Cells: Differences and Similarities

(2018) Venkata Gayatri Dhara et al.   BIODRUGS

Optimization of in vivo DNA delivery with NickFect peptide vectors

(2016) Krista Freimann et al.   JOURNAL OF CONTROLLED RELEASE

New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids

(2013) Piret Arukuusk et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Overcoming Nonviral Gene Delivery Barriers: Perspective and Future

(2013) Charles H. Jones et al.   MOLECULAR PHARMACEUTICS

PepFect14 Peptide Vector for Efficient Gene Delivery in Cell Cultures

(2012) Kadi-Liis Veiman et al.   MOLECULAR PHARMACEUTICS